Skip to content
Peter Attia MDPeter Attia MD

260 ‒ Men’s Sexual Health: why it matters, what can go wrong, and how to fix it

Full episode and show notes: https://bit.ly/3Pu6LL0 Become a member for exclusive content: https://peterattiamd.com/subscribe/ Peter's email newsletter: https://peterattiamd.com/newsletter/ Mohit Khera is a urologist with expertise in sexual medicine. In this episode, he provides an overview of male sexual health. He first goes in-depth on erectile dysfunction, shedding light on its prevalence across different age groups, diagnostic methods, and its intriguing connection to cardiovascular disease. He then ventures into Peyronie's disease, penile fractures, penile enlargement treatments, prolonged erections, premature ejaculation, and anorgasmia. Mohit then delves into the intricate workings of testosterone, DHT, and estrogen, emphasizing their physiological significance and interplay. He explains blood tests for diagnosing low T, the correlation between symptoms and blood levels in cases of low T, and the various methods for increasing testosterone. He concludes with a conversation about the role of testosterone in patients with prostate cancer and addresses concerns surrounding DHT, finasteride, and post-finasteride syndrome. We discuss: 0:00:00 - Intro 0:01:18 - Mohit’s career path and interest in sexual medicine 0:03:25 - The anatomy of the male genitalia 0:05:06 - The prevalence of sexual dysfunction & impact on quality of life 0:08:58 - Erectile dysfunction (ED): definition, diagnosis, pathophysiology 0:13:41 - The history of medications to treat ED and the mechanisms of how they work 0:18:21 - Relationship between aging & erectile dysfunction and Mohit's approach to treating patients 0:29:14 - The impact of lifestyle on sexual health & the association between ED and cardiovascular disease 0:37:52 - Causes and treatments for Peyronie’s Disease & penile fracture 0:48:32 - The value of ultrasound for ED diagnosis and management strategies 0:51:55 - Various treatment options for ED: injections, penile prosthesis 0:59:38 - Priapism (prolonged erection) 1:05:40 - Shockwave therapy as a treatment for ED 1:11:46 - Stem cell therapy for ED 1:15:48 - Platelet-rich plasma (PRP) injections as a treatment for ED 1:18:36 - Premature ejaculation (PE): prevalence, pathophysiology, and treatment 1:26:34 - Anorgasmia: causes and treatment 1:31:52 - Sex hormones, impact of aging, symptoms of low T, & considerations for testosterone replacement therapy (TRT) 1:44:49 - Methods for increasing endogenous testosterone 2:00:03 - Testosterone replacement therapy: various forms of exogenous testosterone & weighing risk vs. reward 2:11:03 - The physiology and purpose of testosterone and DHT, why some men feel fine even with “low” testosterone, personalized approaches to treating low T 2:18:25 - Post-finasteride syndrome 2:26:42 - The role of testosterone in prostate cancer and addressing the notion that TRT could increase risk 2:38:29 - The effects of testosterone as an adjunct to therapy for estrogen-sensitive breast cancer in women 2:40:08 - Resources for those looking for healthcare providers - About: The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, and all that goes into that from physical to cognitive to emotional health. With over 60 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health & more. Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan. Learn more: https://peterattiamd.com Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Podcasts: http://bit.ly/TheDriveGoogle Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit my website where I keep an up-to-date and active list of such companies. For a full list of our registered and unregistered trademarks, trade names, and service marks, please review our Terms of Use: https://peterattiamd.com/terms-of-use/

Mohit KheraguestPeter Attiahost
Jun 26, 20232h 42mWatch on YouTube ↗

At a glance

WHAT IT’S REALLY ABOUT

Urologist Mohit Khera on Male Sexual Dysfunction, Testosterone, and Emerging Therapies

  1. Khera says sexual dysfunction is very common, with ED affecting roughly 40% of men at 40 and rising by decade, yet men suffer in silence because of embarrassment and because clinicians rarely ask.
  2. ED is framed as an early warning of cardiovascular disease, mostly driven by venous leak and endothelial dysfunction, and responds to lifestyle changes, daily tadalafil, injections, or a penile prosthesis.
  3. Khera is cautious about shockwave, stem cell and PRP therapies for ED, calling them promising but still investigational and often oversold, with shockwave the one he likes best.
  4. On testosterone, he argues symptoms matter more than numbers, favors calculated free T, and prefers twice-weekly subcutaneous injections for men committed to TRT while warning that starting TRT can suppress fertility and the endogenous axis.
  5. He distrusts finasteride because of post-finasteride syndrome, and he cites bipolar androgen therapy and a saturation model to argue testosterone does not drive prostate cancer.

IDEAS WORTH REMEMBERING

5 ideas

Men suffer in silence with sexual dysfunction

Khera cites a survey in which only 51% of affected men told their doctor and 44% told their partner, mainly from embarrassment, while clinicians often don't ask because of time pressure.

ED can be an early sign of cardiovascular disease

Khera cites studies showing that organic ED often precedes cardiac events, with endothelial dysfunction as the prevailing common link, so lifestyle changes like diet, exercise, sleep and stress reduction matter.

Daily low-dose tadalafil is more than an on-demand pill

Khera sees 5 mg daily Cialis as helping tissue health, breaking the psychogenic vicious cycle, treating BPH, and possibly improving systemic endothelial function, and notes generics are now very cheap.

Work out whether ED is psychogenic or organic first

Khera says that good erections with masturbation or on waking suggest psychogenic ED, treated with sex therapy and daily tadalafil, and that penile ultrasound can show arterial insufficiency versus venous leak.

Newer ED treatments are promising but not proven

Khera says shockwave devices vary widely, stem cell and PRP lack placebo-controlled trials, and patients are vulnerable to expensive claims given a high placebo response.

WORDS WORTH SAVING

5 quotes

That's suffering in silence, and the main reason was they were embarrassed. Also, clinicians don't ask about it.

— Mohit Khera

So when you take Viagra, you are not curing your ED, you're just covering it that night while the disease continues to progress.

— Mohit Khera

It's the first sign of cardiovascular disease. Numerous studies have shown that.

— Mohit Khera

I never understood why we use this number 300. What are you telling me? 300 nanogram is a, is the definition for hypogonadism. So are you telling me that 290 we must all feel bad, and at 310 we must all feel good? That is not true.

— Mohit Khera

The science is coming up, and I would say that it may be beneficial for patients who have mild to moderate ED. But I just... Be careful on the ads that are given

— Mohit Khera

Erectile dysfunction prevalence and pathophysiologyED as a cardiovascular warning signPeyronie's disease and priapismPenile prosthesis and injection therapyShockwave, stem cell and PRP therapiesPremature ejaculation and delayed orgasmTestosterone replacement therapy options

High quality AI-generated summary created from speaker-labeled transcript.

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.

iOSAndroidClaudeChromeChatGPTComing soon